Skip to main content
SpringerLink
Log in

Treatment of the Neck in Carcinoma of the Parotid Gland

  • Head and Neck Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To review our experience in the treatment of the neck in patients with carcinoma of the parotid gland.

Methods

A total of 263 patients were stratified into 3 groups: no neck dissection (NoND), elective neck dissection (END), and therapeutic neck dissection (TND). Clinicopathological characteristics of END and TND versus NoND were compared by Chi square test. Pathological positivity of each neck level was quantified. Neck recurrence–free survival was determined by Kaplan–Meier statistics.

Results

There were 232 cN0 and 31 cN+ patients. Of the cN0 patients, 74 had END. All cN+ patients had TND. Of the END group, occult neck metastases were detected in 26 (35 %) patients. The percentage of positivity was 6.7, 28.3, 21.3, 10.8, and 6.7 % for levels I to V, respectively. Compared to the NoND group, the END group was more likely to be over 60 years old, to have cT3T4 disease, and to have disease with more aggressive histology. Of the TND group, pathological positivity was found in 87 %. The percentage of positivity was 51.6, 77, 73, 53, and 40 % for levels I to V, respectively. Patients who had disease-positive necks had a poorer neck recurrence-free survival of 84.8 %.

Conclusions

In patients with cN0 disease, observation of the neck is safe in those who are under 60 years of age with clinical T1 or T2 tumors and who have low-grade histology. END should be carried out in patients with cT3T4 disease or high-grade histology and should involve levels II to IV at a minimum. Patients with cN+ disease commonly have all neck levels involved and therefore should be managed with comprehensive neck dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Spiro RH, Huvos AG, Strong EW. A clinicopathologic study of 288 primary cases. Cancer of the parotid gland. Am J Surg. 1975;130:452–9.

    Article  CAS  PubMed  Google Scholar 

  2. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69:615–9.

    Article  CAS  PubMed  Google Scholar 

  3. Kelley DJ, Spiro RH. Management of the neck in parotid carcinoma. Am J Surg. 1996;172:695–7.

    Article  CAS  PubMed  Google Scholar 

  4. Kawata R, Koutetsu L, Yoshimura K, Nishikawa S, Takenaka H. Indication for elective neck dissection for N0 carcinoma of the parotid gland: a single institution’s 20-year experience. Acta Otolaryngol. 2010;130:286–92.

    Article  PubMed  Google Scholar 

  5. Klussmann JP, Ponert T, Mueller RP, Dienes HP, Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol. 2008;34:932–7.

    Article  CAS  PubMed  Google Scholar 

  6. Zbaren P, Schupbach J, Nuyens M, Stauffer E. Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg. 2005;132:387–91.

    Article  CAS  PubMed  Google Scholar 

  7. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck. 1988;10:160–7.

    Article  CAS  Google Scholar 

  8. Herman MP, Werning JW, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM. Elective neck management for high-grade salivary gland carcinoma. Am J Otolaryngol. 2013;34:205–8.

    Article  PubMed  Google Scholar 

  9. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg. 1989;115:316–21.

    Article  CAS  PubMed  Google Scholar 

  10. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702–8.

    Article  PubMed  Google Scholar 

  11. Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am. 1998;31:815–22.

    Article  CAS  PubMed  Google Scholar 

  12. Kim MJ, Kim JS, Roh JL, et al. Utility of (18)F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection. Ann Surg Oncol. 2013;20:899–905.

    Article  PubMed  Google Scholar 

  13. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–8.

    Article  CAS  PubMed  Google Scholar 

  14. Al-Mamgani A, van Rooij P, Verduijn GM, Meeuwis CA, Levendag PC. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. Int J Radiat Oncol Biol Phys. 2012;84:189–95.

    Article  PubMed  Google Scholar 

  15. Chen AM, Garcia J, Lee NY, Bucci MK, Eisele DW. Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys. 2007;67:988–94.

    Article  PubMed  Google Scholar 

  16. Rodriguez-Cuevas S, Labastida S, Baena L, Gallegos F. Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy. Eur Arch Otorhinolaryngol. 1995;252:139–42.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Safina Ali MD, Frank L. Palmer BA, Monica DiLorenzo BA, Jatin P. Shah MD, Snehal G. Patel MD & Ian Ganly MD, PhD

Authors
  1. Safina Ali MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank L. Palmer BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica DiLorenzo BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jatin P. Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Snehal G. Patel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ian Ganly MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Ganly MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, S., Palmer, F.L., DiLorenzo, M. et al. Treatment of the Neck in Carcinoma of the Parotid Gland. Ann Surg Oncol 21, 3042–3048 (2014). https://doi.org/10.1245/s10434-014-3681-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3681-y

Keywords

Search

Navigation